insights_auto
Sebab MYGN meningkat 5.78%?
Terokai Dengan Lebih Terperincichevron_right
MYGN:NASDAQ
Myriad Genetics Inc
USD 4.21
arrow_upward
+5.78%(+0.23) 1H
USD 4.21
0.00% (0.00)
bedtimeSelepas waktu pejabat
Ditutup: 19 Okt, 4:00:01 PTG GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk MYGN...
Buka
USD 4.01
Tinggi
USD 4.24
Rendah
USD 3.95
Permodalan Pasaran
402.68J
Purata volum
2.00J
Volum
1.36J
tgi 52 mgu
USD 8.50
rdh 52 mgu
USD 2.74
EPS
-USD 1.20
Beta
1.64
Syer tertunggak
95.65J
Bilangan pekerja
3K
Buka
USD 4.01
Tinggi
USD 4.24
Rendah
USD 3.95
Permodalan Pasaran
402.68J
Purata volum
2.00J
Volum
1.36J
tgi 52 mgu
USD 8.50
rdh 52 mgu
USD 2.74
EPS
-USD 1.20
Beta
1.64
Syer tertunggak
95.65J
Bilangan pekerja
3K
Cerita berita
Daripada sumber web dan rakan kongsi berita
www.tokenpost.com
·
2 hari lalu
Dan Kirsche Sees Strong U.S. Stock Gains in November and December
Astro Awani
·
32 minit lalu
Nasdaq climbs as chip and AI-linked stocks bounce back
Kalkine Media
·
21 minit lalu
Can Medical Strength Meet Reform Talk at Aurora Cannabis (NASDAQ:ACB)?
Profil
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
Perihal Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Pekerja2.7K
Diasaskan1991
Ibu pejabatSalt Lake City, Utah, Amerika Syarikat
Sektor-
Laman webmyriad.com